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ABSTRACT
Medicaid programs play a dual role in the
opioid crisis, financing both prescription
opioids for pain relief and treatment
medications like buprenorphine. We examined
state-level changes in the volume of pain
reliever opioids and treatment opioids in
Medicaid, as well as changes in opioid mortality
rates between 2012 and 2016, for a nonelderly, adult population. The national average
utilization of pain reliever opioids per adult
enrollee fell sharply, by about one-quarter
across the board in both expansion and nonexpansion states alike, while the level of
treatment opioids per enrollee rose by over
50% in expansion states, and 10% in nonexpansion states.
Multivariate models indicate that Medicaid
expansions had no significant effect on per
enrollee utilization of pain reliever opioids or
treatment opioids, nor on changes in opioid
mortality rates, contrary to a recent report
made by the Senate Committee on Homeland
Security and Governmental Affairs1.

DATA & METHODS
We combined multiple data sources to construct a state-level database for each year from 2012 to
2016. The variables of interest in our database are:
1. The total volume of prescription refills for pain reliever and treatment opioids reimbursed by
Medicaid.
2. The number of non-elderly adult Medicaid enrollees.
3. Opioid mortality rates.
4. Unemployment rates.
5. Expansion status.
6. State capacity to provide drug abuse treatment for Medicaid enrollees.
We used multivariate, two-way fixed effects linear regression models, controlling for states, years,
and time-invariant differences across states, to examine factors associated with changes in opioid
prescriptions from 2012 through 2016. The use of year fixed effects controls for national level
secular trends, such as changing professional recommendations about prescription opioid use or
treatment approaches, entry of new medications and drug price changes.

• To examine overall and per-capita changes in
the levels of prescriptions for pain reliever
and treatment opioids across all states from
2012 through 2016.
• To examine what factors are significantly
associated with changes in the level of
prescriptions for pain reliever and treatment
opioids across states and over time.

Table 1 presents results of a two-way fixed
effects model. Changes in pain reliever opioid
refills were significantly associated with opioid
mortality rate, unemployment rate, and time;
whereas changes in treatment opioid refills
were statistically associated solely with opioid
mortality rate.

RESULTS
Figures 1 & 2, respectively, present data on the changes in average per-enrollee Medicaid
prescriptions for pain reliever and treatment opioids from 2012 to 2016 between expansion and
non-expansion states (we exclude early and late Medicaid expansion states and look only at the 41
states that either expanded Medicaid in 2014 or states that had not expanded through 2016).
Prescriptions for pain reliever opioids fell by 28% and 24% in expansion and non-expansion states,
respectively; prescriptions for treatment opioids rose by 56% and 10% in expansion and nonexpansion states, respectively.

The two main factors associated with changes
in medication use per adult Medicaid enrollee
were the 1) state levels of opioid use disorder,
as measured by mortality rates, and 2) time.
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Fig. 2: Changes in Avg.
Number of Prescriptions for
Treatment Opioids per
Enrollee

Fig. 1: Changes in Avg.
Number of Prescriptions for
Pain Reliever Opioids per
Enrollee
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CONCLUSIONS
Our simple and multivariate analyses indicate
that Medicaid expansion did not have a
significant impact on opioid use across states or
over time. Strong effects of time on pain
reliever opioid prescription rates suggest that
as awareness of the opioid epidemic grew,
providers changed their prescribing patterns.
Although increases in prescriptions for
treatment opioids were unrelated to expansion,
the expansion greatly increased the scope of
treatment for drug abuse by providing states
that were already hard-hit by the crisis with the
funding they needed to expand treatment to
cover a greater number of low-income and atrisk adults.
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